UK-based medtech Perspectum bags $36M for its AI-powered advanced imaging tech -- TFN

A precision health company developing medical imaging tools to improve the diagnosis of metabolic diseases and cancer, Perspectum, has completed the first close of its Series C funding round. The company's $36 million investment round was led by Oppenheimer Holdings. With this, the total funding raised by the company accounts for $120 million. Perspectum is working to expand its footprint across the country and grow its customer base. In addition to scaling up its US operations, Perspectum will use the new funding to accelerate its product pipeline for multiorgan inflammatory conditions and oncology.